LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 15 of 15: Time-dependent dose-response metrics for biological replicate 3. - Dataset (ID:20323)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Time Point (hr) | Time Interval (hr) | GR50 | GEC50 | GRmax | GRinf | GR Hill Coefficient | GR_AOC |
---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 54.25 | 11.9 | 2.4281 | 8.3283 | -0.3369 | -1.0000 | 1.0304 | 0.2327 |
MCF 10A-H2B-mCherry | Dasatinib | 55.97 | 11.9 | 4.1363 | 6.7932 | -0.4294 | -1.0000 | 3.3320 | 0.2248 |
MCF 10A-H2B-mCherry | Neratinib | 57.67 | 11.9 | 0.4637 | 1.3072 | -0.6943 | -1.0000 | 1.2533 | 0.2654 |
MCF 10A-H2B-mCherry | Palbociclib | 73.49 | 11.9 | 3.8592 | 5.0055 | -0.9830 | -1.0000 | 4.3323 | 0.1600 |
MCF 10A-H2B-mCherry | Neratinib | 55.97 | 11.9 | 0.4248 | 1.1732 | -0.6983 | -1.0000 | 1.2159 | 0.2772 |
MCF 10A-H2B-mCherry | Etoposide | 18.49 | 11.9 | 1.6291 | 11.8949 | 0.0238 | -1.0000 | 0.5835 | 0.2602 |
MCF 10A-H2B-mCherry | Palbociclib | 80.31 | 11.9 | 3.7073 | 4.6207 | -0.9998 | -1.0000 | 5.0000 | 0.2973 |
MCF 10A-H2B-mCherry | Neratinib | 80.31 | 11.9 | Inf | Inf | -1.0000 | -1.0000 | 0.0000 | 0.3828 |
MCF 10A-H2B-mCherry | Neratinib | 73.49 | 11.9 | Inf | Inf | -1.0000 | -1.0000 | 0.0000 | 0.4286 |
MCF 10A-H2B-mCherry | Palbociclib | 76.90 | 11.9 | 3.8753 | 4.8812 | -0.9978 | -1.0000 | 4.7782 | 0.1974 |
MCF 10A-H2B-mCherry | Dasatinib | 49.15 | 11.9 | 0.8818 | 11.0074 | -0.2493 | -1.0000 | 0.4675 | 0.3252 |
MCF 10A-H2B-mCherry | Neratinib | 76.90 | 11.9 | Inf | Inf | -1.0000 | -1.0000 | 0.0000 | 0.3500 |
MCF 10A-H2B-mCherry | Dasatinib | 52.56 | 11.9 | 1.4789 | 9.4423 | -0.2797 | -1.0000 | 0.6283 | 0.2800 |
MCF 10A-H2B-mCherry | Dasatinib | 50.86 | 11.9 | 1.1058 | 12.4343 | -0.2680 | -1.0000 | 0.4767 | 0.3013 |
MCF 10A-H2B-mCherry | Etoposide | 16.79 | 11.9 | 2.2187 | 15.6011 | 0.0196 | -1.0000 | 0.6178 | 0.2349 |
MCF 10A-H2B-mCherry | Alpelisib | 89.69 | 11.9 | Inf | Inf | -0.9954 | -0.9954 | 0.0000 | 1.0518 |
MCF 10A-H2B-mCherry | Palbociclib | 85.43 | 11.9 | Inf | Inf | -0.9917 | -0.9933 | 0.6160 | 0.5482 |
MCF 10A-H2B-mCherry | Palbociclib | 85.43 | 12.0 | Inf | Inf | -0.9908 | -0.9912 | 0.5687 | 0.5120 |
MCF 10A-H2B-mCherry | Alpelisib | 85.43 | 11.9 | Inf | Inf | -0.9874 | -0.9874 | 0.0000 | 0.8979 |
MCF 10A-H2B-mCherry | Alpelisib | 85.43 | 12.0 | Inf | Inf | -0.9870 | -0.9870 | 0.0000 | 0.8881 |
MCF 10A-H2B-mCherry | Palbociclib | 89.69 | 11.9 | Inf | Inf | -0.9796 | -0.9796 | 0.0000 | 0.6834 |
MCF 10A-H2B-mCherry | Neratinib | 54.25 | 11.9 | 0.45 | 1.3349 | -0.6369 | -0.9728 | 1.2215 | 0.2717 |
MCF 10A-H2B-mCherry | Etoposide | 80.31 | 11.9 | Inf | Inf | -0.9514 | -0.9514 | 0.0000 | 1.1514 |
MCF 10A-H2B-mCherry | Alpelisib | 80.31 | 11.9 | Inf | Inf | -0.9481 | -0.9481 | 0.0000 | 0.4247 |
MCF 10A-H2B-mCherry | Dasatinib | 89.69 | 11.9 | Inf | Inf | -0.9466 | -0.9466 | 0.0000 | 1.1164 |